BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou H, Zhang Y, Wei X, Yang K, Tan W, Qiu Z, Li S, Chen Q, Song Y, Gao S. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study. Cancer Med 2017;6:2745-56. [PMID: 28980417 DOI: 10.1002/cam4.1220] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Greenberg JA, Ivanov NA, Egan CE, Lee YJ, Zarnegar R, Fahey TJ 3rd, Finnerty BM, Min IM. Sex-Based Clinicopathologic and Survival Differences Among Patients with Pancreatic Neuroendocrine Tumors. J Gastrointest Surg 2022. [PMID: 35915373 DOI: 10.1007/s11605-022-05345-6] [Reference Citation Analysis]
2 Nnorom SO, Akinyemi O, Tran J, Baig H, Cornwell EE, Wilson LL. Color or money?: The impact of socioeconomic status and race/ethnicity on breast cancer mortality. The American Journal of Surgery 2022. [DOI: 10.1016/j.amjsurg.2022.07.013] [Reference Citation Analysis]
3 Abdel-Rahman O, Ghosh S. A Real-World Study of the Incidence and Outcomes of Early-Onset Well-differentiated Neuroendocrine Neoplasms. Am J Clin Oncol 2022. [PMID: 35696696 DOI: 10.1097/COC.0000000000000925] [Reference Citation Analysis]
4 Zheng-Pywell R, Lopez-Aguiar A, Fields RC, Vickers S, Yates C, Dudeja V, Chen H, Reddy S, Maithel SK, Rose JB. Are We Undertreating Black Patients with Nonfunctional Pancreatic Neuroendocrine Tumors? Critical Analysis of Current Surveillance Guidelines by Race. J Am Coll Surg 2022;234:599-606. [PMID: 35380181 DOI: 10.1097/XCS.0000000000000105] [Reference Citation Analysis]
5 Wang J, Liu J, He C, Sun T, Yan Y, Che G, Li X, Sun H, Ma H. Trends in Incidence and Survival of Patients with Pancreatic Neuroendocrine Neoplasm, 1987-2016. J Oncol 2021;2021:4302675. [PMID: 34976056 DOI: 10.1155/2021/4302675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Underwood PW, Riner AN, Neal D, Cameron ME, Yakovenko A, Reddy S, Rose JB, Hughes SJ, Trevino JG. It's more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumors. J Surg Oncol 2021. [PMID: 34499741 DOI: 10.1002/jso.26667] [Reference Citation Analysis]
7 Bingmer KE, Hue JJ, Sugumar K, Ammori JB, Rothermel LD, Winter JM, Hardacre JM, Ocuin LM. Racial disparities in operative management of localized, non-functional pancreatic neuroendocrine tumors in surgically fit patients. HPB (Oxford) 2021:S1365-182X(21)00589-X. [PMID: 34247942 DOI: 10.1016/j.hpb.2021.06.418] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zheng-Pywell R, Fang A, AlKashash A, Awad S, Reddy S, Vickers S, Heslin M, Dudeja V, Chen H, Rose JB. Prognostic Impact of Tumor Size on Pancreatic Neuroendocrine Tumor Recurrence May Have Racial Variance. Pancreas 2021;50:347-52. [PMID: 33835965 DOI: 10.1097/MPA.0000000000001776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kriger AG, Berelavichus SV, Kaldarov AR, Gorin DS, Raevskaya MB, Kazennov VV, Zekster VY, Panteleev VI. Organ‐preserving procedures as an option for treatment of patients with pancreatic neuroendocrine tumours. Surg Pract 2021;25:4-9. [DOI: 10.1111/1744-1633.12473] [Reference Citation Analysis]
10 Chen J, Yang Y, Liu Y, Kan H. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation. World J Surg Oncol 2021;19:11. [PMID: 33436017 DOI: 10.1186/s12957-020-02115-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kessler J, Singh G, Ituarte PHG, Allen R, Chang S, Li D. A Comparison of Liver-Directed Therapy and Systemic Therapy for the Treatment of Liver Metastases in Patients with Gastrointestinal Neuroendocrine Tumors: Analysis of the California Cancer Registry. J Vasc Interv Radiol 2021;32:393-402. [PMID: 33358144 DOI: 10.1016/j.jvir.2020.10.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lu L, Shang Y, Mullins CS, Zhang X, Linnebacher M. Epidemiologic trends and prognostic risk factors of patients with pancreatic neuroendocrine neoplasms in the US: an updated population-based study. Future Oncol 2021;17:549-63. [PMID: 33401958 DOI: 10.2217/fon-2020-0543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kessel E, Naparst M, Alpert N, Diaz K, Ahn E, Wolin E, Taioli E, Kim MK. Racial Differences in Gastroenteropancreatic Neuroendocrine Tumor Treatment and Survival in the United States. Pancreas 2021;50:29-36. [PMID: 33370020 DOI: 10.1097/MPA.0000000000001707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Goksu SY, Ozer M, Beg MS, Sanford NN, Ahn C, Fangman BD, Goksu BB, Verma U, Sanjeevaiah A, Hsiehchen D, Jones AL, Kainthla R, Kazmi SM. Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors. Cancers (Basel) 2020;12:E2990. [PMID: 33076486 DOI: 10.3390/cancers12102990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Goksu SY, Ozer M, Kazmi SMA, Sanford NN, Aguilera TA, Ahn C, Hsiehchen D, Sanjeevaiah A, Khosama L, Bleeker J, Atiq M, Beg MS. Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor. Cancers (Basel) 2020;12:E2501. [PMID: 32899271 DOI: 10.3390/cancers12092501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Riner AN, Underwood PW, Yang K, Herremans KM, Cameron ME, Chamala S, Qiu P, George TJ, Permuth JB, Merchant NB, Trevino JG. Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes. Cancer Med 2020;9:4069-82. [PMID: 32285629 DOI: 10.1002/cam4.3042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
17 Low SK, Giannis D, Bahaie NS, Trong BLH, Moris D, Huy NT. Competing Mortality in Patients With Neuroendocrine Tumors. Am J Clin Oncol 2019;42:668-74. [PMID: 31343423 DOI: 10.1097/COC.0000000000000575] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 de Jager E, Levine AA, Udyavar NR, Burstin HR, Bhulani N, Hoyt DB, Ko CY, Weissman JS, Britt LD, Haider AH, Maggard-Gibbons MA. Disparities in Surgical Access: A Systematic Literature Review, Conceptual Model, and Evidence Map. J Am Coll Surg 2019;228:276-98. [PMID: 30803548 DOI: 10.1016/j.jamcollsurg.2018.12.028] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 28.5] [Reference Citation Analysis]
19 Lee L, Ito T, Jensen RT. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Rev Anticancer Ther. 2019;19:1029-1050. [PMID: 31738624 DOI: 10.1080/14737140.2019.1693893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
20 Gosain R, Ball S, Rana N, Groman A, Gage-Bouchard E, Dasari A, Mukherjee S. Geographic and demographic features of neuroendocrine tumors in the United States of America: A population-based study. Cancer 2020;126:792-9. [PMID: 31714595 DOI: 10.1002/cncr.32607] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
21 Weber F, Dralle H. Value of ileus-prophylactic surgery for metastatic neuroendocrine midgut tumours. Best Pract Res Clin Endocrinol Metab 2019;33:101342. [PMID: 31628078 DOI: 10.1016/j.beem.2019.101342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Wu J, Ye J, Wu W, Fang D, Wang K, Yang L, Jiang X, Wang Q, Li L. Racial disparities in young-onset patients with colorectal, breast and testicular cancer. J Cancer 2019;10:5388-96. [PMID: 31632483 DOI: 10.7150/jca.32435] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 DePalo DK, Lee RM, Lopez-Aguiar AG, Gamboa AC, Rocha F, Poultsides G, Dillhoff M, Fields RC, Idrees K, Nathan H, Abbott D, Maithel SK, Russell MC; other members of the United States Neuroendocrine Tumor Study Group. Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity? J Surg Oncol 2019;120:919-25. [PMID: 31385621 DOI: 10.1002/jso.25662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
24 Wu J, Sun C, Li E, Wang J, He X, Yuan R, Yi C, Liao W, Wu L. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality. BMC Cancer 2019;19:334. [PMID: 30961556 DOI: 10.1186/s12885-019-5543-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
25 Li G, Tian ML, Bing YT, Tao LY, Wang HY, Jiang B, Yuan CH, Xiu DR. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article. Medicine (Baltimore) 2019;98:e14576. [PMID: 30882623 DOI: 10.1097/MD.0000000000014576] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
26 Song Y, Gao S, Tan W, Qiu Z, Zhou H, Zhao Y. Multiple Machine Learnings Revealed Similar Predictive Accuracy for Prognosis of PNETs from the Surveillance, Epidemiology, and End Result Database. J Cancer 2018;9:3971-8. [PMID: 30410601 DOI: 10.7150/jca.26649] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
27 Zhou H, Zhang Y, Wei X, Yang K, Tan W, Qiu Z, Li S, Chen Q, Song Y, Gao S. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study. Cancer Med 2017;6:2745-56. [PMID: 28980417 DOI: 10.1002/cam4.1220] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]